Gefitinib toxicity has been significantly correlated with survival in non-small cell lung cancer patients treated in EAP program in Czech Republic

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	ZEMANOVÁ Milada PETRUZELKA Luboš ZATLOUKAL Petr PEŠEK Miloš GRYGÁROVÁ Ivona SKŘIČKOVÁ Jana SVOBODNÍK Adam VRÁNA David
Year of publication	2007
Type	Article in Proceedings
Conference	Journal of Thoracic Oncology
MU Faculty or unit	Faculty of Medicine
Citation
Field	Oncology and hematology
Keywords	Gefitinib; toxicity; non-small cell lung cancer;survival
Description	Toxicity of the anti-tumour drug, Gefitinib, has been followed up in a multi-center study of non-small cell lung cancer and correlated with patients' survival. The results in the Czech leg of the study have suggested a significant correlation.
Related projects:	Environment - carcinogenesis - oncology